Exchange: TSX·Updated 04:00 PM EDT

GUD.TSX Knight Therapeutics Inc

$11.31
$0.27
(2.45%)
Today
EarningsNov 5
Mkt Cap$1.08B
Vol93,763.00

About GUD.TSX

Knight Therapeutics, Inc. engages in the business of acquiring, in licensing, out-licensing, marketing, and commercializing pharmaceuticals products. The firm also focuses on building a portfolio of innovative products through in-licensing or acquiring product rights. The company was founded by Jonathan Ross Goodman on November 1, 2013 and is headquartered in Montréal, Canada.
50

Neutral Sentiment

How do you feel about GUD.TSX?

Advertisement|Remove ads.